Ariad's $5.2 Billion Sale To Takeda Nets $260 Million Windfall For Hedge Fund |
| January 10, 2017 | January 2017 Bond Updates |
|
Sarissa Capital, run by Carl Icahn protégé Alex Denner, stands to make $260 million from Takeda's $5.2 billion takeover of Ariad Pharmaceuticals. |
| View more at: http://www.forbes.com/sites/antoinegara/2017/01/09/ariads-5-2-billion-sale-to-takeda-nets-260-million-windfall-for-hedge-fund/ |
| Related News |
|